<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38453258</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1399-3003</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The European respiratory journal</Title><ISOAbbreviation>Eur Respir J</ISOAbbreviation></Journal><ArticleTitle>A proposed approach to pulmonary long COVID: a viewpoint.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2302302</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/13993003.02302-2023</ELocationID><Abstract><AbstractText><b>A majority of patients with pulmonary long COVID have small airway disease, characterised by inflammation, which can be diagnosed with traditional and emerging technologies</b> https://bit.ly/48WceB3</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gerayeli</LastName><ForeName>Firoozeh V</ForeName><Initials>FV</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eddy</LastName><ForeName>Rachel L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sin</LastName><ForeName>Don D</ForeName><Initials>DD</Initials><Identifier Source="ORCID">0000-0002-0756-6643</Identifier><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada Don.Sin@hli.ubc.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Respir J</MedlineTA><NlmUniqueID>8803460</NlmUniqueID><ISSNLinking>0903-1936</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="eng"><AbstractText>Long COVID (also known as &#x201c;post-acute sequelae of COVID-19&#x201d;) is a multi-system disorder that follows an acute bout of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection [1]. Although its exact prevalence is unknown, it is estimated to affect approximately 10% of SARS-CoV-2-infected individuals, though in reality the proportion is likely much higher owing to under-reporting of cases [1]. The prevalence is elevated in patients who have had acute SARS-CoV-2 pneumonia requiring hospitalisation, and lower in those who have been previously vaccinated or were infected with the Omicron variant [1]. In approximately 6% of the cases of long COVID, pulmonary symptoms such as dyspnoea, cough and wheeziness are prominent, leading to considerable disability and morbidity [2, 3]. While it is attractive to view long COVID as one disease, it is likely a very complex, heterogeneous disorder, with multiple different phenotypes, each driven by a unique set of molecules and pathways [1]. Even within an organ system (<i>e.g.</i> the lungs), there is likely to be significant heterogeneity in the phenotypes of disease. Here, we hypothesise that patients with long COVID with a predominance of pulmonary symptoms (which we will refer to in this viewpoint editorial as &#x201c;pulmonary long COVID&#x201d;, or PLC) have airway pathology that can be detected using conventional as well as emerging technologies, and careful phenotyping of this condition will provide important insights on its mechanism(s) and reveal novel biomarkers and therapeutic solutions for millions around the world with PLC.</AbstractText></OtherAbstract><CoiStatement>Conflict of interest: F.V. Gerayeli has no potential conflicts of interest to disclose. R.L. Eddy reports grants or contracts from Michael Smith Health Research BC, and Canadian Respiratory Research Network, consulting fees from VIDA Diagnostics Inc, and an honorarium for a presentation from Thorasys Thoracic Medical Systems, outside the submitted work. D.D. Sin reports honoraria from GSK, AZ, and BI, outside the submitted work; and is chair of a data and safety monitoring board for a COPD clinical trial for NHLBI.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>0</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>8</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>7</Day><Hour>20</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38453258</ArticleId><ArticleId IdType="pmc">PMC11391093</ArticleId><ArticleId IdType="doi">10.1183/13993003.02302-2023</ArticleId><ArticleId IdType="pii">13993003.02302-2023</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, et al. . Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023; 21: 133&#x2013;146. doi:10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Postacute sequelae of COVID-19 at 2&#x2005;years. Nat Med 2023; 29: 2347&#x2013;2357. doi:10.1038/s41591-023-02521-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med 2022; 28: 1706&#x2013;1714. doi:10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerayeli FV, Park HY, Milne S, et al. . Single cell sequencing reveals cellular landscape alterations in the airway mucosa of patients with pulmonary long COVID. Eur Respir J 2024; in press [10.1183/13993003.01947-2023].</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01947-2023</ArticleId></ArticleIdList></Reference><Reference><Citation>Medical Research Council's Committee on the Aetiology of Chronic Bronchitis . Standardized questionaries on respiratory symptoms. Br Med J 1960; 2: 1665.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Comstock GW, Tockman MS, Helsing KJ, et al. . Standardized respiratory questionnaires: comparison of the old with the new. Am Rev Respir Dis 1979; 119: 45&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">420437</ArticleId></ArticleIdList></Reference><Reference><Citation>Guinto E, Gerayeli FV, Eddy RL, et al. . Post-COVID-19 dyspnoea and pulmonary imaging: a systematic review and meta-analysis. Eur Respir Rev 2023; 32: 220253. doi:10.1183/16000617.0253-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0253-2022</ArticleId><ArticleId IdType="pmc">PMC10410398</ArticleId><ArticleId IdType="pubmed">37558261</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JL, Villacreses R, Nagpal P, et al. . Quantitative chest CT assessment of small airways disease in post-acute SARS-CoV-2 infection. Radiology 2022; 304: 185&#x2013;192. doi:10.1148/radiol.212170</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.212170</ArticleId><ArticleId IdType="pmc">PMC9270680</ArticleId><ArticleId IdType="pubmed">35289657</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah B, Ahmad MN, Khalid M, et al. . Long COVID and wavering incidence of pulmonary embolism: a systematic review. J Community Hosp Intern Med Perspect 2023; 13: 23&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10589046</ArticleId><ArticleId IdType="pubmed">37868668</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh YJ, Hong H, Ohana M, et al. . Pulmonary embolism and deep vein thrombosis in COVID-19: a systematic review and meta-analysis. Radiology 2021; 298: E70&#x2013;E80. doi:10.1148/radiol.2020203557</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020203557</ArticleId><ArticleId IdType="pmc">PMC7745997</ArticleId><ArticleId IdType="pubmed">33320063</ArticleId></ArticleIdList></Reference><Reference><Citation>Eddy RL, Mummy D, Zhang S, et al. . Cluster analysis to identify long COVID phenotypes using 129Xe magnetic resonance imaging: a multicentre evaluation. Eur Respir J 2024; 63: 2302301. doi:10.1183/13993003.02301-2023</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02301-2023</ArticleId><ArticleId IdType="pmc">PMC10973687</ArticleId><ArticleId IdType="pubmed">38331459</ArticleId></ArticleIdList></Reference><Reference><Citation>Washko GR, Parraga G. COPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging. Eur Respir J 2018; 52: 1801570. doi:10.1183/13993003.01570-2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01570-2018</ArticleId><ArticleId IdType="pubmed">30337445</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo HK, Vasilescu DM, Booth S, et al. . Small airways disease in mild and moderate chronic obstructive pulmonary disease: a cross-sectional study. Lancet Respir Med 2018; 6: 591&#x2013;602. doi:10.1016/S2213-2600(18)30196-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(18)30196-6</ArticleId><ArticleId IdType="pubmed">30072106</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingul CB, Edvardsen A, Follestad T, et al. . Changes in cardiopulmonary exercise capacity and limitations 3&#x2013;12&#x2005;months after COVID-19. Eur Respir J 2023; 61: 2200745. doi:10.1183/13993003.00745-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00745-2022</ArticleId><ArticleId IdType="pmc">PMC9515478</ArticleId><ArticleId IdType="pubmed">36137587</ArticleId></ArticleIdList></Reference><Reference><Citation>King GG, Bates J, Berger KI, et al. . Technical standards for respiratory oscillometry. Eur Respir J 2020; 55: 1900753. doi:10.1183/13993003.00753-2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00753-2019</ArticleId><ArticleId IdType="pubmed">31772002</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamminen P, Kerimov D, Viskari H, et al. . Lung function during and after acute respiratory infection in COVID-19 positive and negative outpatients. Eur Respir J 2022; 59: 2102837. doi:10.1183/13993003.02837-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02837-2021</ArticleId><ArticleId IdType="pmc">PMC8785400</ArticleId><ArticleId IdType="pubmed">35058250</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaramuzzo G, Ronzoni L, Campo G, et al. . Long-term dyspnea, regional ventilation distribution and peripheral lung function in COVID-19 survivors: a 1&#x2005;year follow up study. BMC Pulm Med 2022; 22: 408. doi:10.1186/s12890-022-02214-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-022-02214-5</ArticleId><ArticleId IdType="pmc">PMC9643983</ArticleId><ArticleId IdType="pubmed">36352423</ArticleId></ArticleIdList></Reference><Reference><Citation>Merenstein C, Bushman FD, Collman RG. Alterations in the respiratory tract microbiome in COVID-19: current observations and potential significance. Microbiome 2022; 10: 165. doi:10.1186/s40168-022-01342-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-022-01342-8</ArticleId><ArticleId IdType="pmc">PMC9532226</ArticleId><ArticleId IdType="pubmed">36195943</ArticleId></ArticleIdList></Reference><Reference><Citation>Kooner HK, McIntosh MJ, Matheson AM, et al. . Postacute COVID-19 syndrome: 129Xe MRI ventilation defects and respiratory outcomes 1 year later. Radiology 2023; 307: e222557. doi:10.1148/radiol.222557</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.222557</ArticleId><ArticleId IdType="pmc">PMC9926501</ArticleId><ArticleId IdType="pubmed">36749209</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Bier EA, Swaminathan A, et al. . Diverse cardiopulmonary diseases are associated with distinct xenon magnetic resonance imaging signatures. Eur Respir J 2019; 54: 1900831. doi:10.1183/13993003.00831-2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00831-2019</ArticleId><ArticleId IdType="pmc">PMC7271066</ArticleId><ArticleId IdType="pubmed">31619473</ArticleId></ArticleIdList></Reference><Reference><Citation>Grist JT, Collier GJ, Walters H, et al. . Lung abnormalities detected with hyperpolarized 129Xe MRI in patients with long COVID. Radiology 2022; 305: 709&#x2013;717. doi:10.1148/radiol.220069</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.220069</ArticleId><ArticleId IdType="pmc">PMC9134268</ArticleId><ArticleId IdType="pubmed">35608443</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheson AM, McIntosh MJ, Kooner HK, et al. . Longitudinal follow-up of postacute COVID-19 syndrome: DLCO, quality-of-life and MRI pulmonary gas-exchange abnormalities. Thorax 2023; 78: 418&#x2013;421. doi:10.1136/thorax-2022-219378</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thorax-2022-219378</ArticleId><ArticleId IdType="pmc">PMC10086459</ArticleId><ArticleId IdType="pubmed">36596692</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders LC, Collier GJ, Chan HF, et al. . Longitudinal lung function assessment of patients hospitalized with COVID-19 using 1H and 129Xe lung MRI. Chest 2023; 164: 700&#x2013;716. doi:10.1016/j.chest.2023.03.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2023.03.024</ArticleId><ArticleId IdType="pmc">PMC10036146</ArticleId><ArticleId IdType="pubmed">36965765</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerayeli FV, Milne S, Yang CX, et al. . Single-cell RNA sequencing of bronchoscopy specimens: development of a rapid minimal handling protocol. Biotechniques 2023; 75: 157&#x2013;167. doi:10.2144/btn-2023-0017</Citation><ArticleIdList><ArticleId IdType="doi">10.2144/btn-2023-0017</ArticleId><ArticleId IdType="pubmed">37815826</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, Jamil R, Chowdhury A, et al. . Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur Respir J 2023; 61: 2200970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L, Chen L, Li X, et al. . Analysis of lung microbiome in COVID-19 patients during time of hospitalization. Pathogens 2023; 12: 944. doi:10.3390/pathogens12070944</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens12070944</ArticleId><ArticleId IdType="pmc">PMC10386632</ArticleId><ArticleId IdType="pubmed">37513791</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>